Removal of cannabis from Schedule I of the Controlled Substances Act

Lawsuit Seeks Equal Treatment for Cannabis Businesses

Retrieved on: 
Thursday, October 26, 2023
Poseidon, Supreme court, Cannabis, Executive (government), Sale, Controlled Substances Act, Small business, OTCQX, Congress, Commerce, Court, Federation, Ground substance, Law of the United Kingdom, Risk, District court, Freedom, Western Division, Executive branch of the government of Honduras, Verano, War, Seed, Removal of cannabis from Schedule I of the Controlled Substances Act, Investment, SBA, Patient, Commerce Clause, Constitution, Plaintiff, TSX, CSA, SAFER, Drug

SPRINGFIELD, Mass., Oct. 26, 2023 /PRNewswire/ -- A coalition of U.S. cannabis operators and investors working in state-legal medical and adult-use cannabis markets today filed a lawsuit against U.S. Attorney General Merrick Garland. The coalition, represented by the law firm Boies Schiller Flexner, seeks to enjoin the federal government from enforcing the Controlled Substances Act in a manner that interferes with the intrastate cultivation, manufacture, possession, and distribution of cannabis, pursuant to state law. The lawsuit asserts that the federal government has no basis for enforcing the Controlled Substances Act against intrastate, state-regulated cannabis operations.

Key Points: 
  • The lawsuit asserts that the federal government has no basis for enforcing the Controlled Substances Act against intrastate, state-regulated cannabis operations.
  • The lawsuit seeks to confirm the rights of Massachusetts and other states to regulate cannabis within their borders, and to confirm the corresponding limits on the federal government's power to regulate commerce.
  • Absent the relief sought in this lawsuit, Plaintiffs and other state-regulated cannabis operators will continue to suffer severe harms.
  • The result is that many cannabis businesses are suffering, people are losing their jobs and individual wealth is being destroyed.

Benzinga Cannabis Capital Conference Returns at a Pivotal Moment as the Federal Government Considers Relaxing Marijuana Laws

Retrieved on: 
Friday, September 22, 2023
Controlled Substances Act, IRS, Senate, SAFE, Secure, Ground substance, Removal of cannabis from Schedule I of the Controlled Substances Act, Schedule, Cannabis, Growth, United States Senate Committee on Banking, Housing, and Urban Affairs, SAFE Banking Act, Conference, Legislation, Drug

CHICAGO, Sept. 22, 2023 /PRNewswire/ -- As favorable forces align within the cannabis industry, the Benzinga Cannabis Capital Conference is set to commence in Chicago on September 27-28, 2023, at the Marriott Magnificent Mile. The event will gather the most influential investors and business leaders at a pivotal time for the industry.

Key Points: 
  • The event will gather the most influential investors and business leaders at a pivotal time for the industry.
  • Foremost among these transformative forces is the anticipation of a federal rescheduling of cannabis to a Schedule III substance under the Controlled Substances Act.
  • "The Benzinga Cannabis Capital Conference is coming at a crucial time for the industry.
  • Benzinga provides discounted tickets for the conference to cannabis business owners who have obtained state certification for their social equity initiatives.

American Council of Cannabis Medicine Prepares DEA Rescheduling Application; Backs HHS Directive on Cannabis Rescheduling Industry Input Opens This Week

Retrieved on: 
Thursday, September 21, 2023
Controlled Substances Act, Insurance, Drug, Optimism, Legislation, ACCM, HHS, Capitol Hill, Committee, Health, Human, Research, American Council, Ground substance, Removal of cannabis from Schedule I of the Controlled Substances Act, Human voice, Schedule, Congress, DEA, Patient, Physician, CGO, Council, Drug Enforcement Agency, Cannabis, Capitol, Letter, United States Department of Health and Human Services, List of streets in Baltimore

Dr. Annabelle Manalo-Morgan, author, research scientist, and Chair of ACCM's Research Committee, expressed enthusiasm about the potential this shift holds for medical cannabis.

Key Points: 
  • Dr. Annabelle Manalo-Morgan, author, research scientist, and Chair of ACCM's Research Committee, expressed enthusiasm about the potential this shift holds for medical cannabis.
  • Recognizing our responsibility as the leading voice for medical cannabis, we initiated the DEA cannabis rescheduling application process and anticipate its finalization by October."
  • The ACCM is currently taking input on its DEA application from members of Congress and invites industry stakeholders to share their insights until October 30th, 2023,via www.accmforum.org/deavoice
    The American Council of Cannabis Medicine is the "Voice of American Medical Cannabis."
  • Reach the American Council of Cannabis Medicine at 202-349-9650, or www.accmforum.org
    Explore ACCM's Next Frontier Task Force at: www.nextfrontier.us

Endexx Provides Insight on Possible New Federal Cannabis Regulations

Retrieved on: 
Tuesday, September 12, 2023
Controlled Substances Act, Research, HHS, United States Department of Health and Human Services, United States farm bill, CSA, Public, Policy, OTCQB, Federal, Removal of cannabis from Schedule I of the Controlled Substances Act, Government, Hemp, Science, 2018 United States farm bill, CAVE, DEA, Risk, Cannabis industry, Cannabis, FDA, Drug

CAVE CREEK, AZ, Sept. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced insight on potential benefits of the new statements made concerning reclassification of Marijuana/Cannabis. Statements recently provided by the FDA and HHS to the DEA indicate a new policy stance at the Federal level versus the political theatre. A policy shift at the federal level provides a pathway forward for Research Institutions and US investment banking to finally participate in the cannabis industry.

Key Points: 
  • Statements recently provided by the FDA and HHS to the DEA indicate a new policy stance at the Federal level versus the political theatre.
  • A policy shift at the federal level provides a pathway forward for Research Institutions and US investment banking to finally participate in the cannabis industry.
  • This marks the first significant policy shift regarding Marijuana/Cannabis by the FDA since Cannabis was made illegal.
  • As a pioneer in the hemp and cannabis industries, Endexx has been recognized as an innovator and leader in many aspects of this nascent industry.

“House of Ho” star Washington Ho launches HoBuzz THC seltzer

Retrieved on: 
Thursday, August 31, 2023
Networking hardware, Controlled Substances Act, Energy drink, Seafood, Delta, Drinking, Removal of cannabis from Schedule I of the Controlled Substances Act, Ground substance, Water, CBD, THC, Six pack, House, Drug, Soft drink

HOUSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Washington Ho – Houston entrepreneur and star of “House of Ho” on Max – has partnered with Tony Buzbee to launch HoBuzz, a non-alcoholic, Delta-8 THC infused seltzer.

Key Points: 
  • HOUSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Washington Ho – Houston entrepreneur and star of “House of Ho” on Max – has partnered with Tony Buzbee to launch HoBuzz, a non-alcoholic, Delta-8 THC infused seltzer.
  • Produced by Houston’s 8th Wonder Brewery and Bayou City Hemp Co., HoBuzz is now available by the 6-pack with nationwide shipping at hobuzzco.com .
  • “One of my biggest struggles with being sober was that the products in the marketplace did not fit my lifestyle,” Ho said.
  • I can’t wait to share this with the world.”
    Each 12-ounce can of HoBuzz is infused with 10 milligrams of nano-emulsified, hemp-derived Delta-8 THC.

Greenberg Traurig Atlanta Welcomes Back Mellori E. Lumpkin-Dawson, Expands Labor & Employment and Litigation Practices

Retrieved on: 
Wednesday, July 19, 2023
Controlled Substances Act, LLP, Employment Act of 1946, Employment, Family and Medical Leave Act of 1993, University, Education, Age Discrimination in Employment Act of 1967, Anti-Kickback Statute, State government, UC Berkeley School of Law, Ground substance, Removal of cannabis from Schedule I of the Controlled Substances Act, Civil Rights Act, Ageism, Employment practices liability, Law, Florida A&M University, Civil Rights Act of 1964, Family, Labour, Insurance, Private investigator, Practice of law, Greenberg Traurig

ATLANTA, July 19, 2023 /PRNewswire-PRWeb/ -- Mellori E. Lumpkin-Dawson rejoined global law firm Greenberg Traurig, LLP's Atlanta office as of counsel in the Labor & Employment and Litigation Practices. Lumpkin-Dawson returns to the firm after four and a half years with the U.S. Attorney's Office for the Northern District of Georgia.

Key Points: 
  • Mellori E. Lumpkin-Dawson rejoined global law firm Greenberg Traurig, LLP's Atlanta office as of counsel in the Labor & Employment and Litigation Practices.
  • ATLANTA, July 19, 2023 /PRNewswire-PRWeb/ -- Mellori E. Lumpkin-Dawson rejoined global law firm Greenberg Traurig, LLP 's Atlanta office as of counsel in the Labor & Employment and Litigation Practices.
  • Lumpkin-Dawson, who served as an Assistant U.S. Attorney and Civil Elder Justice Coordinator, now focuses on employment litigation at Greenberg Traurig.
  • "We are excited to welcome Mellori back to Greenberg Traurig's Atlanta office, enhancing our Labor & Employment Practice's significant litigation capabilities," said Richard J. Valladares, chair of Greenberg Traurig's Atlanta Business Litigation Group and Administrative Shareholder of the firm's Atlanta office.

RISE Dispensaries Ironically “Celebrates” Richard Nixon with “Thanks, Dick” Campaign

Retrieved on: 
Wednesday, July 12, 2023
Controlled Substances Act, CSE, Education, Policy, Ground substance, Removal of cannabis from Schedule I of the Controlled Substances Act, Helene Curtis Industries, Inc., RISE, War, Dispensary, Green Thumb, Drug

The “Thanks, Dick” campaign recognizes the destructive consequences of the Controlled Substances Act, which effectively initiated the War on Drugs and decades of harm on communities of color.

Key Points: 
  • The “Thanks, Dick” campaign recognizes the destructive consequences of the Controlled Substances Act, which effectively initiated the War on Drugs and decades of harm on communities of color.
  • “The ‘Thanks, Dick’ campaign is a way to acknowledge the harmful aspects of cannabis history while advocating for a better future.
  • RISE also encourages consumers to sign its petition in support of cannabis scheduling reform and watch the informational video on its website .
  • For more information about the “Thanks, Dick” campaign or RISE Dispensaries, please visit risecannabis.com .

Bright Green Announces Historic Federal Registration and License Approval from the U.S. Drug Enforcement Administration Confirming Bright Green as a Bulk Manufacturer of Cannabis

Retrieved on: 
Monday, May 1, 2023
Controlled Substances Act, Greenhouse, State, Partnership, Timeline of cannabis laws in the United States, Drug development, COGS, Bright Green, McAuley, CSA, International Narcotics Control Board, Cannabinoid, Licensure, Research, Medicine, USCIS, EB-5, Immigration, Movement, Removal of cannabis from Schedule I of the Controlled Substances Act, Green, Acquisition, DEA, Patient, Cannabis, Growth, FDA, News, Drug, Pharmaceutical industry, Grant

This process included an audit of both our manufacturing and extraction facilities, as well as the greenhouse currently under construction.

Key Points: 
  • This process included an audit of both our manufacturing and extraction facilities, as well as the greenhouse currently under construction.
  • Bright Green Executive Chairman and Chairman of the Board Terry Rafih said, “This is an exciting moment for Bright Green.
  • I want to thank the entire Bright Green team for their hard work as well as our legal advisors who have been instrumental in helping us secure this monumental and historic achievement.
  • Bright Green is now able and willing to fulfill this need and the potential market opportunity in the U.S. and abroad.

InvestmentPitch Media Video Discusses THC BioMed’s Launch of Sales and Exports of its Patented “Clone Shipper” Product to Asia

Retrieved on: 
Thursday, March 2, 2023
Drink, BioMed Central, Suggestion, Cannabis, FSE, Humidity, THC, News, Risk, Plant, Prohibition of drugs, Temperature, Removal of cannabis from Schedule I of the Controlled Substances Act, Brazilian Controlled Drugs and Substances Act, Hand, CSE, Drug

The video is available for viewing on “ InvestmentPitch ” and on “ YouTube ”.

Key Points: 
  • The video is available for viewing on “ InvestmentPitch ” and on “ YouTube ”.
  • If these links are not enabled, please visit www.InvestmentPitch.com and enter “THC BioMed” in the search box.
  • The virtually indestructible container is manufactured in North America and can be purchased online at www.CloneShipper.com or in Asia through THC BioMed Thailand.
  • THC BioMed has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format.

Guidepost Solutions Expands DEA Regulatory Compliance Practice

Retrieved on: 
Tuesday, February 28, 2023
Technology, Other Defense, Security, Transport, Logistics, Supply Chain Management, Retail, Data Management, Defense, California Department of Justice, Pharmacy, Special Operations Division, Special agent, Corruption, Guide Post, Ground substance, Acquisition, DEA, Drug Enforcement Administration, Violence, Diversion, Narcotic, Sandström, Private sector, Justice, Personnel recovery, Removal of cannabis from Schedule I of the Controlled Substances Act, History, Illegal drug trade, Modernization of Investigative Techniques Act, International, Bell, Controlled Substances Act, Pharmacist, Physician, Drug, Audit

Guidepost Solutions , a global leader in domestic and international investigations, compliance solutions, monitoring, and security and technology consulting, announced the expansion of its Drug Enforcement Administration (DEA) Regulatory Compliance Practice .

Key Points: 
  • Guidepost Solutions , a global leader in domestic and international investigations, compliance solutions, monitoring, and security and technology consulting, announced the expansion of its Drug Enforcement Administration (DEA) Regulatory Compliance Practice .
  • “Under Krista’s direction and bolstered by a team of respected experts, our DEA Regulatory Compliance Practice continues to ensure our clients’ compliance with federal and state laws and regulations,” said Julie Myers Wood, CEO of Guidepost Solutions.
  • Guidepost is well-suited to help companies take the appropriate actions to meet any regulatory requirement.”
    Recent additions to the Guidepost DEA Regulatory Compliance Practice include:
    Robert J.
  • Additional Guidepost DEA Regulatory Compliance team members include:
    Krista Tongring , senior managing director, leads the Guidepost DEA Regulatory Compliance practice and oversees a variety of compliance engagements, monitorships, and investigatory matters.